Recent Quotes (30 days)

You have no recent quotes
chg | %

VANC Pharmaceuticals Inc  

(Public, CVE:NPH)   Watch this stock  
Find more results for CVE:APH
0.000 (0.00%)
Nov 21 - Close
CVE data delayed by 15 mins - Disclaimer
Currency in CAD
Range 0.17 - 0.19
52 week 0.07 - 0.23
Open 0.19
Vol. 375,310.00
Mkt cap 6.62M
P/E     -
Div/yield     -
EPS -0.03
Shares 36.77M
Beta 0.86
Inst. own     -

Key stats and ratios

Q2 (Jun '14) 2014
Net profit margin - -
Operating margin - -
EBITD margin - -
Return on average assets -111.11% -90.53%
Return on average equity -138.03% -133.47%
CDP Score - -


11782 River Rd Suite 152
+1-604-6872038 (Phone)
+1-604-6873141 (Fax)

Website links


Vanc Pharmaceuticals Inc, formerly Nuva Pharmaceuticals Inc., is engaged in the business of developing infection control products for industrial and consumer use and for the treatment of topical infections. The Company�s first product, a surface disinfectant called T36 Disinfex. It is being sold primarily to First Responder organizations, including ambulance, fire fighters and police forces in Canada; dental clinics, and beauty and hair care salons and spas.

Officers and directors

Arun D. Nayyar Chief Executive Officer
Jamie A. Lewin Chief Financial Officer, Secretary, Director
Eugene Beukman Secretary, Independent Director
Sina Pirooz Director
Thomas J. Kennedy Independent Director